Lactoferrin: Antimicrobial activity and therapeutic potential

被引：92

作者：

Embleton, Nicholas D. ^{[1
,2
]}

Berrington, Janet E. ^{[1
,2
]}

McGuire, William ^{[3
]}

Stewart, Chris J. ^{[4
]}

Cummings, Stephen P. ^{[4
]}

机构：

[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Neonatal Serv, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England

[2] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England

[3] Univ York, Ctr Reviews & Disseminat, Natl Inst Hlth Res, York YO10 5DD, N Yorkshire, England

[4] Northumbria Univ, Sch Life Sci, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England

来源：

SEMINARS IN FETAL & NEONATAL MEDICINE | 2013年 / 18卷 / 03期

关键词：

Lactoferrin; Late-onset infection; Microbiome; Necrotising enterocolitis; RECOMBINANT HUMAN LACTOFERRIN; PREVENTING PRETERM DELIVERY; NECROTIZING ENTEROCOLITIS; BOVINE LACTOFERRIN; RANDOMIZED-TRIAL; MILK-PROTEINS; ESCHERICHIA-COLI; NEONATAL SEPSIS; GUT MICROBIOTA; INFANTS;

D O I：

10.1016/j.siny.2013.02.001

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

Lactoferrin is a highly conserved protein from an evolutionary perspective, with a wide range of roles related to protection from infection and promotion of nutritional status. Infection, malnutrition and intestinal pathologies are key inter-related problems, represent important threats to survival and are associated with adverse long-term health outcomes after preterm birth. Lactoferrin is available as a commercial extract from bovine milk and offers potential as a therapeutic intervention for preterm infants modulating infections and intestinal pathologies. In this review we explore the structure, direct antimicrobial effects, modification of host immune function and gastrointestinal effects of lactoferrin. Current trial data are reviewed, and research priorities and challenges identified and discussed. (c) 2013 Elsevier Ltd. All rights reserved.

引用

页码：143 / 149

页数：7

共 50 条

[11] Microbial Biosurfactants: Antimicrobial Activity and Potential Biomedical and Therapeutic Exploits
Puyol McKenna, Patricia
Naughton, Patrick J.
Dooley, James S. G.
Ternan, Nigel G.
Lemoine, Patrick
Banat, Ibrahim M.
PHARMACEUTICALS, 2024, 17 (01)
[12] The molecular characterisation and antimicrobial activity of amidated bovine lactoferrin
Pan, Y.
Shiell, B.
Wan, J.
Coventry, M. J.
Roginski, H.
Lee, A.
Michalski, W. P.
INTERNATIONAL DAIRY JOURNAL, 2007, 17 (06) : 606 - 616
[13] ENHANCED ANTIMICROBIAL ACTIVITY OF LACTOFERRIN BY BINDING TO THE BACTERIAL SURFACE
DALMASTRI, C
VALENTI, P
VISCA, P
VITTORIOSO, P
ORSI, N
MICROBIOLOGICA, 1988, 11 (03): : 225 - 230
[14] MIOCAMYCIN - A REVIEW OF ITS ANTIMICROBIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL
HOLLIDAY, SM
FAULDS, D
DRUGS, 1993, 46 (04) : 720 - 745
[15] CLARITHROMYCIN - A REVIEW OF ITS ANTIMICROBIAL ACTIVITY, PHARMACOKINETIC PROPERTIES AND THERAPEUTIC POTENTIAL
PETERS, DH
CLISSOLD, SP
DRUGS, 1992, 44 (01) : 117 - 164
[16] Human lactoferrin: a novel therapeutic with broad spectrum potential
Weinberg, ED
JOURNAL OF PHARMACY AND PHARMACOLOGY, 2001, 53 (10) : 1303 - 1310
[17] Antimicrobial peptides: therapeutic potential
Zhang, LJ
Falla, TJ
EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (06) : 653 - 663
[18] Antimicrobial activity of recombinant human lactoferrin from Aspergillus awamori, human milk lactoferrin and their hydrolysates
Celia Conesa
María Carmen Rota
María-Dolores Pérez
Miguel Calvo
Lourdes Sánchez
European Food Research and Technology, 2008, 228 : 205 - 211
[19] Antimicrobial activity of recombinant human lactoferrin from Aspergillus awamori, human milk lactoferrin and their hydrolysates
Conesa, Celia
Rota, Maria Carmen
Perez, Maria-Dolores
Calvo, Miguel
Sanchez, Lourdes
EUROPEAN FOOD RESEARCH AND TECHNOLOGY, 2008, 228 (02) : 205 - 211
[20] Potential lactoferrin activity against pathogenic viruses
Redwan, Elrashdy M.
Uversky, Vladimir N.
El-Fakharany, Esmail M.
Al-Mehdar, Hussein
COMPTES RENDUS BIOLOGIES, 2014, 337 (10) : 581 - 595

← 1 2 3 4 5 →